THE DEKEYSER GROUP PRACTICE — All Prescriptions & Medications — Page 8
Practice Code: B86067 | LEEDS, LS27 9EN
Showing results 351-400 of 713
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Trospium chloride | 76 | 2,584 | £1.7K | +48.9% ▲ |
| Canagliflozin | 75 | 2,176 | £2.7K | -47.8% ▼ |
| Menthol | 75 | 22.7K | £828 | +166.3% ▲ |
| 75 | 545 | £1.2K | +209.6% ▲ | |
| Risedronate sodium | 74 | 380 | £98 | -39.0% ▼ |
| Bezafibrate | 73 | 1,134 | £282 | +35.5% ▲ |
| 73 | 73 | £339 | +42.3% ▲ | |
| Adrenaline | 72 | 167 | £9.6K | +14.2% ▲ |
| Dorzolamide | 71 | 2,755 | £1.2K | -14.6% ▼ |
| 71 | 4,128 | £10.5K | +78.0% ▲ | |
| Insulin degludec | 70 | 403 | £3.8K | -36.3% ▼ |
| Timolol | 70 | 1,805 | £477 | -20.9% ▼ |
| Cefradine | 69 | 1,055 | £646 | +628.9% ▲ |
| Urea | 69 | 35.3K | £1.3K | +3.3% ▲ |
| Amiodarone hydrochloride | 68 | 1,820 | £105 | +5.4% ▲ |
| Hydralazine hydrochloride | 68 | 2,268 | £125 | +61.2% ▲ |
| Levonorgestrel | 68 | 68 | £5.5K | +80.2% ▲ |
| Liquid OTC glucose for diabetic hypo treatment (0913541) | 68 | 45.8K | £711 | +196.7% ▲ |
| Flecainide acetate | 67 | 4,090 | £168 | -14.2% ▼ |
| 67 | 5,820 | £4.0K | +502.4% ▲ | |
| Moxonidine | 66 | 2,156 | £303 | +18.6% ▲ |
| Flupentixol hydrochloride | 66 | 2,913 | £393 | +200.9% ▲ |
| Ivermectin | 66 | 3,285 | £1.9K | +210.4% ▲ |
| 66 | 5,056 | £10.6K | +95.4% ▲ | |
| 66 | 1,050 | £1.3K | +101.0% ▲ | |
| Etonogestrel | 65 | 65 | £5.4K | +124.9% ▲ |
| Glycerol | 63 | 888 | £137 | +79.6% ▲ |
| Mercaptopurine | 63 | 2,455 | £1.1K | +306.9% ▲ |
| Prednisolone acetate | 63 | 390 | £136 | +245.6% ▲ |
| Erythromycin ethylsuccinate | 61 | 9,500 | £855 | +161.3% ▲ |
| Co-trimoxazole(Trimethoprim/sulfamethoxazole) | 61 | 1,774 | £131 | +51.8% ▲ |
| Ciclosporin (Eye Anti Inflammatory) | 61 | 2,825 | £6.8K | +146.0% ▲ |
| 61 | 5,897 | £10.4K | +188.1% ▲ | |
| Betamethasone sodium phosphate | 60 | 815 | £226 | +131.6% ▲ |
| Inclisiran | 59 | 59 | £3.0K | +368.4% ▲ |
| Colestyramine | 57 | 3,092 | £777 | +97.9% ▲ |
| Ciprofloxain/dexameth | 57 | 345 | £402 | +85.6% ▲ |
| Cimetidine | 56 | 3,948 | £384 | +200.2% ▲ |
| Trifluoperazine | 56 | 392 | £478 | +271.2% ▲ |
| Tamsulosin and dutasteride hydrochloride | 56 | 690 | £200 | +60.2% ▲ |
| Amorolfine hydrochloride | 56 | 280 | £348 | +142.5% ▲ |
| Dabigatran etexilate | 55 | 2,688 | £2.2K | +6.2% ▲ |
| Dipyridamole | 55 | 3,660 | £763 | +114.2% ▲ |
| Pioglitazone hydrochloride | 55 | 1,260 | £55 | -37.8% ▼ |
| Dexamethasone | 55 | 1,946 | £1.1K | -7.9% ▼ |
| Fluorouracil (Sunscreen) | 55 | 2,210 | £1.8K | +51.0% ▲ |
| 55 | 630 | £1.7K | +15.0% ▲ | |
| Enoxaparin | 54 | 1,822 | £9.4K | +163.5% ▲ |
| Travoprost | 54 | 175 | £112 | +14.6% ▲ |
| 54 | 2,670 | £378 | +25.3% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.